ArticleG3 (Bethesda, Md.)2026
Structural bases of signal generation and transduction by the SPS amino acid sensor of Saccharomyces cerevisiae.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ssy1 in Saccharomyces cerevisiae is an amino acid receptor evolved from amino acid transporters. It is situated in the plasma membrane in the SPS complex, together with the WD40-repeat protein Ptr3 and the endoprotease Ssy5. Binding of extracellular amino acids to Ssy1 triggers liberation of the catalytic domain of Ssy5, which removes an inhibitory domain from the transcription factor Stp1, freeing it to activate genes encoding amino acid transporters. We mapped 7 constitutively signaling and hyper-responsive SSY1 mutations onto AlphaFold and Phyre2-based 3D models of Ssy1 to inform conformational steps involved in signaling. The predictions suggest a model in which an occluded, inward-facing conformation of Ssy1 leads to signaling. The mutations suggest a hinge in TM12 which, combined with a C-terminal "latch," offers a mechanism for signaling. AlphaFold 3 modeling suggests that conserved sequence boxes in the N-terminal cytoplasmic domain of Ssy1 serve as interaction faces for binding of Ptr3, Ssy5, and casein kinases Yck1 and Yck2 (Yck). In addition, interaction faces between Ptr3 and Ssy5 were predicted. Antagonism between phosphorylation and dephosphorylation of Ptr3 and Ssy5 by Yck and Protein Phosphatase 2A (PP2A) is key in signaling. We found Yck phosphorylation motifs as well as binding motifs for regulatory subunit Rts1 of PP2A in both Ptr3 and Ssy5. These motifs, together with sites of PTR3 and SSY5 gain-of-function mutations, were mapped onto AlphaFold models of Ptr3 and Ssy5. The results constitute a basis for predicting novel aspects of phosphorylation in the signaling mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.